Matches in Wikidata for { <http://www.wikidata.org/entity/Q66061441> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q66061441 description "assaig clínic" @default.
- Q66061441 description "clinical trial" @default.
- Q66061441 description "clinical trial" @default.
- Q66061441 description "clinical trial" @default.
- Q66061441 description "clinical trial" @default.
- Q66061441 description "ensaio clínico" @default.
- Q66061441 description "ensayo clínico" @default.
- Q66061441 description "ensayu clínicu" @default.
- Q66061441 description "essai clinique" @default.
- Q66061441 description "klinisch onderzoek" @default.
- Q66061441 description "клінічне випробування" @default.
- Q66061441 name "Phase I Study of Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)" @default.
- Q66061441 name "Phase I Study of Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1" @default.
- Q66061441 type Item @default.
- Q66061441 label "Phase I Study of Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)" @default.
- Q66061441 label "Phase I Study of Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1" @default.
- Q66061441 prefLabel "Phase I Study of Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)" @default.
- Q66061441 prefLabel "Phase I Study of Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1" @default.
- Q66061441 P1132 Q66061441-0256E31A-2B70-4742-A0FE-CB037A0EF1C0 @default.
- Q66061441 P1476 Q66061441-FDFBD7EA-D5C5-4F0A-BA49-914143EBBB2E @default.
- Q66061441 P17 Q66061441-9E35B042-6492-4E3F-8E7D-34D7D77EC698 @default.
- Q66061441 P2899 Q66061441-F5F55C71-1E3D-4FD7-AD4C-62430D3EC28A @default.
- Q66061441 P3098 Q66061441-29A5D465-C6B0-42A7-8EF6-3F6346403B0A @default.
- Q66061441 P31 Q66061441-4B00BD57-AE1C-418C-A888-B28347881682 @default.
- Q66061441 P580 Q66061441-6301B3E6-EDBC-4A60-A16D-CA1200012048 @default.
- Q66061441 P582 Q66061441-D1D8A5D2-3380-43CA-9D39-A9D072972B78 @default.
- Q66061441 P6099 Q66061441-80B8C96E-62F6-4D48-A9DF-20581D88F260 @default.
- Q66061441 P6153 Q66061441-5F101D4B-369D-4948-9702-FFF3702F0A71 @default.
- Q66061441 P8363 Q66061441-6B675B88-5F4F-48DA-98B0-56F6C7C7FAD0 @default.
- Q66061441 P1132 "+69" @default.
- Q66061441 P1476 "Phase I Study of Adoptive Immunotherapy for Advanced MUC1* Positive Breast Cancer With Autologous T Cells Engineered to Express a Chimeric Antigen Receptor, huMNC2-CAR44 Specific for a Cleaved Form of MUC1 (MUC1*)" @default.
- Q66061441 P17 Q30 @default.
- Q66061441 P2899 "+18" @default.
- Q66061441 P3098 "NCT04020575" @default.
- Q66061441 P31 Q30612 @default.
- Q66061441 P580 "2019-09-01T00:00:00Z" @default.
- Q66061441 P582 "2022-09-01T00:00:00Z" @default.
- Q66061441 P6099 Q5452194 @default.
- Q66061441 P6153 Q1452369 @default.
- Q66061441 P8363 Q78089383 @default.